# Heron Therapeutics, Inc.: Form 8-K, filed Feb 20, 2025

- Company: [Heron Therapeutics, Inc.](/companies/hrtx.md) (CIK 818033)
- Form: 8-K
- Filed: 2025-02-20
- Accepted by EDGAR: Feb 20, 2025, 13:51 ET
- Period: 2025-02-13
- Accession: 0000950170-25-023958
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/818033/000095017025023958/hrtx-20250213.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/818033/000095017025023958/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/818033/000095017025023958/hrtx-20250213.htm

Filed Feb 20, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-023958. Last ingested by Listed: Oct 27, 2026, 17:10 ET. No prices; not investment advice.